Thelansis

 Sturge-Weber syndrome (SWS) is a neurocutaneous syndrome characterized by angiomas involving the face, choroid, and leptomeninges. Sturge-Weber syndrome (SWS) is caused by mistake (mutation) in the GNAQ gene. This gene makes a protein involved in regulating blood vessels' growth. ·        The exact sturge-weber syndrome (SWS) incidence and prevalence are unknown. One estimate places the incidence at 1 in 20,000-50,000 live births.   Thelansis’s “Sturge-Weber Syndrome (SWS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Sturge-Weber Syndrome (SWS) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China)...

 Sturge-Weber syndrome (SWS) is a neurocutaneous syndrome characterized by angiomas involving the face, choroid, and leptomeninges. Sturge-Weber syndrome (SWS) is caused by mistake (mutation) in the GNAQ gene. This gene makes a protein involved in regulating blood vessels' growth. ·        The exact Sturge-weber syndrome (SWS) incidence and prevalence are unknown. One estimate places the incidence at 1 in 20,000-50,000 live births. Thelansis’s “Sturge-Weber Syndrome (SWS) Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Sturge-Weber Syndrome (SWS) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). KOLs...